Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G HUMPHRIES

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|February 2, 1999
Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapyA H Ingall, J Dixon, A Bailey, et al.
Cell Reports|January 26, 2017
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives GlioblastomaDinesh K Singh, Rahul K Kollipara, Vamsidara Vemireddy, et al.
Cancer Discovery|April 30, 2017
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF MelanomaBanu Eskiocak, Elizabeth A McMillan, Saurabh Mendiratta, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|February 2, 1999
Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapyA H Ingall, J Dixon, A Bailey, et al.
Cell Reports|January 26, 2017
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives GlioblastomaDinesh K Singh, Rahul K Kollipara, Vamsidara Vemireddy, et al.
Cancer Discovery|April 30, 2017
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF MelanomaBanu Eskiocak, Elizabeth A McMillan, Saurabh Mendiratta, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Pageof 4